Abstract |
The utility of reporter genes has gained significant momentum over the last three decades. Reporter genes are used to understand the transcriptional activity of a gene both in vitro and in vivo, and in pathway analysis and drug screening for diseases involving protozoan parasites, and in anti- cancer drug developments. Here, using a human prostate cancer xenograft model (PC3), we describe a method to construct and validate hypoxia reporter genes with different half-lives. Using molecular biology and optical imaging techniques, we have validated the expression of long half-life enhanced green fluorescence protein (EGFP) expression and short half-life luciferase gene expression to report on the spatial and temporal evolution of hypoxia in vivo.
|
Authors | Balaji Krishnamachary, Pierre Danhier, Samata Kakkad, Santosh K Bharti, Zaver M Bhujwalla |
Journal | Methods in molecular biology (Clifton, N.J.)
(Methods Mol Biol)
Vol. 1790
Pg. 113-125
( 2018)
ISSN: 1940-6029 [Electronic] United States |
PMID | 29858787
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- enhanced green fluorescent protein
- Green Fluorescent Proteins
- Luciferases
|
Topics |
- Animals
- Gene Expression Regulation, Neoplastic
- Genes, Reporter
- Green Fluorescent Proteins
(genetics, metabolism)
- Half-Life
- Heterografts
- Humans
- Hypoxia
(physiopathology)
- Luciferases
(genetics, metabolism)
- Male
- Mice
- Mice, SCID
- Molecular Imaging
(methods)
- Neoplasm Transplantation
- Prostatic Neoplasms
(genetics, metabolism, pathology)
- Tumor Cells, Cultured
|